T-cell engager (TCE) specialist Candid Therapeutics has entered into a reverse merger agreement with Rallybio that will allow ...

Candid, which is making bispecifics for immune diseases, has also raised $505 million in a private financing for the newly ...

CEO Mitch Ginsberg says the reverse merger will provide access to public capital. The Valley company plans to add another 100 to 150 brokerages to its platform this year.

Rallybio has inked a deal to combine with fellow clinical-stage biotechnology company Candid Therapeutics in an all-stock reverse merger. Rallybio on Monday said its shareholders will own about 3.65% ...

Aureus Greenway (AUGS) stock jumped 55% on news of a reverse merger with Trump family-backed Powerus, a drone company targeting massive production scale.

Over a year after first agreeing to a reverse merger with Pulmatrix, protein degradation biotech Cullgen has instead opted to be bought by Gyre Therapeutics in a ...

Keto Motors plans a reverse merger with Taza International as Tron Energy takes a 10% stake, backing its ₹300 crore Telangana electric bus plant.

US biotechnology company Candid Therapeutics will go public through a reverse merger with US rare disease drugmaker Rallybio ...

E-Waste, a shell company linked to a nearly $100 million company that owns just one New Jersey deli, announced Tuesday it will enter into a reverse merger with a privately held electric vehicle ...

A special purpose acquisition company (SPAC) is a blank-check company with no business operations, formed to raise capital through an initial public offering (IPO) for the purpose of effecting a ...